✦ LIBER ✦

Treatment of acute leukemia arising from myelodysplastic syndromes with oral idarubicin, etoposide, and 6-thioguanine

✍ Scribed by M. Montillo; A. Tedeschi; A. Olivieri; R. Centurioni; G. Pelliccia; G. Marchegiani; P. Leoni

Book ID: 113240066
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 142 KB
Volume: 18
Category: Article
ISSN: 0145-2126
DOI: 10.1016/0145-2126(94)90246-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide, 6-thioguanine and idarubicin,

Etoposide, 6-thioguanine and idarubicin, an oral combination regimen (ETI) for the induction treatment of acute leukemia

✍ Tapani Ruutu; Erkki Elonen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB

Twenty patients with advanced acute leukemia (16 acute myeloid leukemia (AML), three myeloid blast crisis (BC) of chronic myeloid leukemia (CML), one acute lymphatic leukemia) were treated with a peroral regimen consisting of etoposide 80 mg/m2 and 6-thioguanine 100 mg/m2 twice daily for 5 days, and

Treatment of myelodysplastic syndromes w

Treatment of myelodysplastic syndromes with low-dose oral 6-thioguanine

✍ Spitzer, Thomas R. ;Lazarus, Hillard M. ;Crum, Edward D. ;Weisman, Russell 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

Several cytotoxic agents when used in vitro in very low concentrations have been shown to induce differentiation of leukemic cells. We treated 18 patients with rnyelodysplastic syndromes with lowdose oral 6-thioguanine (6-TG; 20 to 60 rng daily). Four patients demonstrated significant improvement in

Single weekly cytosine arabinoside and o

Single weekly cytosine arabinoside and oral 6-thioguanine in patients with myelodysplastic syndrome and acute myeloid leukemia

✍ N. C. Munshi; G. J. Tricot 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 165 KB

Oral treatment of acute myeloid leukaemi

Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle

✍ T. Ruutu; E. Koivunen; T. Nousiainen; T.-T. Pelliniemi; A. Almqvist; P. Anttila; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

P-305 Treatment of myelodysplastic syndr

P-305 Treatment of myelodysplastic syndrome, acute leukemia and chronic myelomonocytic leukemia with 5-azacytidine: Comparative results from a single centre

✍ Montalvao, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 85 KB